102PMulticenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy
Lee, S C, Chen, S-C, Dai, M-S, Lee, G E, Liu, C-L, Chan, A, Chang, H-K, Tseng, L-M, Chay, W Y, Chow, L W C, Peneyra, J L, Rau, K-M, Wang, H-C, Guancia, A A, Head, M, Chiu, J W Y, Robinson, B, LindmarkТом:
28
Мова:
english
Журнал:
Annals of Oncology
DOI:
10.1093/annonc/mdx654.010
Date:
November, 2017
Файл:
PDF, 46 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
